Wael A Rahman1, Donald S Garbuz, Bassam A Masri. 1. Division of Lower Limb Reconstruction and Oncology, Department of Orthopaedics, University of British Columbia, Vancouver, Canada. dr.waelrahman@gmail.com
Abstract
BACKGROUND: The proportion of total hip arhtoplasties (THAs) associated with corticosteroid use is uncertain, and the mechanisms of corticosteroid-induced osteonecrosis remain unknown. We sought to evaluate the clinical and radiographic outcomes, complications and satisfaction with THA among patients with corticosteroid-induced osteonecrosis. METHODS: We retrospectively assessed functional outcome at a minimum 1-year follow-up using the Western Ontario and MacMaster Universities Arthritis Index (WOMAC); Oxford Hip Score; Short Form (SF)-12; University of California, Los Angeles (UCLA) Activity; and patient satisfaction scores. RESULTS: We included 31 patients (35 hips). The average follow-up was 20 (range 12- 55) months, and the average age at surgery was 47 (range 19-78) years. At follow-up, patients showed significant improvement in all 4 components of the WOMAC (means: function 84, stiffness 75, pain 86, global 84), Oxford-12 (mean 83) and SF-12 (means: mental 40 and physical 48) scores. However, there was no significant improvement in the UCLA Activity scores. Mean patient satisfaction scores were good for pain relief (86), function (80), recreation (77.5) and overall results of surgery (86). Radiographic review at follow-up showed that all components were well fixed with no evidence of loosening. The complication rate was high (17%), with 6 complications in 5 patients (6 of 35 hips). Four patients (4 of 35 hips; 11%) required reoperations. CONCLUSION: Total hip arthroplasty in patients with corticosteroid-induced osteonecrosis of the femoral head is successful in reducing pain and improving function; however, the rate of complications and reoperation is high.
BACKGROUND: The proportion of total hip arhtoplasties (THAs) associated with corticosteroid use is uncertain, and the mechanisms of corticosteroid-induced osteonecrosis remain unknown. We sought to evaluate the clinical and radiographic outcomes, complications and satisfaction with THA among patients with corticosteroid-induced osteonecrosis. METHODS: We retrospectively assessed functional outcome at a minimum 1-year follow-up using the Western Ontario and MacMaster Universities Arthritis Index (WOMAC); Oxford Hip Score; Short Form (SF)-12; University of California, Los Angeles (UCLA) Activity; and patient satisfaction scores. RESULTS: We included 31 patients (35 hips). The average follow-up was 20 (range 12- 55) months, and the average age at surgery was 47 (range 19-78) years. At follow-up, patients showed significant improvement in all 4 components of the WOMAC (means: function 84, stiffness 75, pain 86, global 84), Oxford-12 (mean 83) and SF-12 (means: mental 40 and physical 48) scores. However, there was no significant improvement in the UCLA Activity scores. Mean patient satisfaction scores were good for pain relief (86), function (80), recreation (77.5) and overall results of surgery (86). Radiographic review at follow-up showed that all components were well fixed with no evidence of loosening. The complication rate was high (17%), with 6 complications in 5 patients (6 of 35 hips). Four patients (4 of 35 hips; 11%) required reoperations. CONCLUSION: Total hip arthroplasty in patients with corticosteroid-induced osteonecrosis of the femoral head is successful in reducing pain and improving function; however, the rate of complications and reoperation is high.
Authors: Henning R Johannson; Michael G Zywiel; David R Marker; Lynne C Jones; Mike S McGrath; Michael A Mont Journal: Int Orthop Date: 2010-02-25 Impact factor: 3.075
Authors: Nizar N Mahomed; Matthew H Liang; Earl F Cook; Lawren H Daltroy; Paul R Fortin; Anne H Fossel; Jeffrey N Katz Journal: J Rheumatol Date: 2002-06 Impact factor: 4.666
Authors: Sue C Kaste; Deqing Pei; Cheng Cheng; Michael D Neel; W Paul Bowman; Raul C Ribeiro; Monika L Metzger; Deepa Bhojwani; Hiroto Inaba; Patrick Campbell; Jeffrey E Rubnitz; Sima Jeha; John T Sandlund; James R Downing; Mary V Relling; Ching-Hon Pui; Scott C Howard Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544
Authors: Matthew R Boylan; Dean C Perfetti; Randa K Elmallah; Viktor E Krebs; Carl B Paulino; Michael A Mont Journal: Clin Orthop Relat Res Date: 2015-11-09 Impact factor: 4.176
Authors: Marcus Jäger; Andrea van Wasen; Sebastian Warwas; Stefan Landgraeber; Marcel Haversath; Vitas Group Journal: Orthop Rev (Pavia) Date: 2014-04-22